| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 18 | 0 | 0 | 18 |
| GLI family zinc finger 3 | 17 | 0 | 0 | 17 |
| AR protein | 20 | 0 | 0 | 20 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 15 | 0 | 0 | 15 |
| glucocorticoid receptor [Homo sapiens] | 19 | 0 | 0 | 19 |
| retinoic acid nuclear receptor alpha variant 1 | 18 | 0 | 0 | 18 |
| estrogen-related nuclear receptor alpha | 18 | 0 | 0 | 18 |
| estrogen nuclear receptor alpha | 19 | 0 | 0 | 19 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 16 | 0 | 0 | 16 |
| IDH1 | 5 | 0 | 0 | 5 |
| euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
| chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform 2 | 18 | 0 | 0 | 18 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 17 | 0 | 0 | 17 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| geminin | 14 | 0 | 0 | 14 |
| lethal factor (plasmid) | 3 | 0 | 0 | 3 |
| lamin isoform A-delta10 | 11 | 0 | 0 | 11 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 6 | 1 | 7 |
| Spike glycoprotein | 9 | 0 | 0 | 9 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| SMAD family member 2 | 11 | 0 | 0 | 11 |
| USP1 protein, partial | 9 | 0 | 0 | 9 |
| SMAD family member 3 | 11 | 0 | 0 | 11 |
| TDP1 protein | 18 | 0 | 0 | 18 |
| Microtubule-associated protein tau | 7 | 0 | 0 | 7 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 14 | 0 | 0 | 14 |
| nuclear receptor subfamily 1, group I, member 3 | 17 | 0 | 0 | 17 |
| progesterone receptor | 16 | 0 | 0 | 16 |
| retinoid X nuclear receptor alpha | 16 | 0 | 0 | 16 |
| farnesoid X nuclear receptor | 14 | 0 | 0 | 14 |
| 67.9K protein | 5 | 0 | 0 | 5 |
| peroxisome proliferator-activated receptor delta | 12 | 0 | 0 | 12 |
| peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
| caspase-3 | 4 | 0 | 0 | 4 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 14 | 0 | 0 | 14 |
| activating transcription factor 6 | 9 | 0 | 0 | 9 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
| vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
| heat shock protein beta-1 | 9 | 0 | 0 | 9 |
| mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
| nuclear receptor ROR-gamma isoform 1 | 10 | 0 | 0 | 10 |
| survival motor neuron protein isoform d | 7 | 0 | 0 | 7 |
| Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
| Cellular tumor antigen p53 | 13 | 0 | 0 | 13 |
| Glutamate receptor 2 | 9 | 0 | 0 | 9 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
| ATPase family AAA domain-containing protein 5 | 7 | 0 | 0 | 7 |
| Ataxin-2 | 7 | 0 | 0 | 7 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 7 | 0 | 0 | 7 |
| ATAD5 protein, partial | 8 | 0 | 0 | 8 |
| aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| pregnane X nuclear receptor | 15 | 0 | 0 | 15 |
| G | 15 | 0 | 0 | 15 |
| bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 11 | 0 | 0 | 11 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 10 | 0 | 0 | 10 |
| nuclear receptor subfamily 1, group I, member 2 | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 6 | 0 | 0 | 6 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 8 | 0 | 0 | 8 |
| neuropeptide S receptor isoform A | 6 | 0 | 0 | 6 |
| Interferon beta | 15 | 0 | 0 | 15 |
| HLA class I histocompatibility antigen, B alpha chain | 15 | 0 | 0 | 15 |
| Glucocorticoid receptor | 1 | 18 | 3 | 24 |
| Glycine receptor subunit alpha-1 | 0 | 18 | 0 | 18 |
| Androgen receptor | 0 | 24 | 0 | 24 |
| Glycine receptor subunit beta | 0 | 18 | 0 | 18 |
| Glycine receptor subunit alpha-2 | 0 | 18 | 0 | 18 |
| Glycine receptor subunit alpha-3 | 0 | 18 | 0 | 18 |
| Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
| Inositol hexakisphosphate kinase 1 | 15 | 0 | 0 | 15 |
| cytochrome P450 2C9, partial | 15 | 0 | 0 | 15 |
| Chain A, Beta-lactamase | 6 | 0 | 0 | 6 |
| thioredoxin reductase | 4 | 0 | 0 | 4 |
| pregnane X receptor | 6 | 0 | 0 | 6 |
| Smad3 | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit pi | 7 | 0 | 0 | 7 |
| Progesterone receptor | 0 | 7 | 5 | 14 |
| Androgen receptor | 1 | 6 | 3 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit delta | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 0 | 0 | 7 |
| Adenosine receptor A1 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 0 | 0 | 7 |
| Adenosine receptor A2b | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 0 | 0 | 7 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Mu-type opioid receptor | 0 | 8 | 0 | 8 |
| Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 0 | 0 | 7 |
| GABA theta subunit | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit epsilon | 7 | 0 | 0 | 7 |
| ORF73 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
| Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| Luciferase | 3 | 0 | 0 | 3 |
| interleukin 8 | 4 | 0 | 0 | 4 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| GLS protein | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
| Histone H2A.x | 7 | 0 | 0 | 7 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 1 | 15 | 5 | 22 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 2 | 0 | 0 | 2 |
| Tyrosine-protein kinase Fyn | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 8 | 0 | 8 |
| Integrin alpha-IIb | 2 | 0 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
| Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
| Substance-K receptor | 0 | 4 | 0 | 4 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 8 | 0 | 8 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| Adenosine receptor A2a | 0 | 4 | 0 | 4 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 12 | 0 | 12 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| Vasopressin V1a receptor | 0 | 4 | 1 | 5 |
| Alpha-synuclein | 4 | 2 | 0 | 6 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 2B | 0 | 6 | 0 | 6 |
| Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
| Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
| Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
| Aldehyde oxidase | 0 | 2 | 0 | 2 |
| TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
| UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Estrogen receptor beta | 1 | 7 | 5 | 14 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Cysteinyl leukotriene receptor 1 | 0 | 2 | 0 | 2 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| Bile salt export pump | 0 | 8 | 0 | 8 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 4 | 4 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 2 | 0 | 3 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 3 | 0 | 0 | 3 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| polyprotein | 3 | 0 | 0 | 3 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| Vpr | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 5 | 0 | 5 |
| Multidrug resistance-associated protein 4 | 0 | 5 | 0 | 5 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 3 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
| Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| Estrogen receptor 1 | 0 | 1 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| PINK1 | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| Parkin | 2 | 0 | 0 | 2 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| galactokinase | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| 4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase | 1 | 0 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
| DNA-3-methyladenine glycosylase | 0 | 1 | 0 | 1 |
| Caspase-1 | 1 | 1 | 0 | 2 |
| DNA repair protein RAD52 homolog | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| BH3-interacting domain death agonist | 0 | 1 | 0 | 1 |
| Type 1 InsP3 receptor isoform S2 | 1 | 0 | 0 | 1 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 2 | 1 | 3 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 2 | 1 | 3 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| Aspartyl/asparaginyl beta-hydroxylase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 2 | 0 | 1 | 0 | 1 |
| Bcl2-associated agonist of cell death | 0 | 1 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Histamine H3 receptor | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| Mineralocorticoid receptor | 1 | 3 | 1 | 6 |
| Androgen receptor | 0 | 0 | 1 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| bioA | 0 | 0 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Tegument protein VP16 | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 1 | 3 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 0 | 1 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 2 | 2 | 4 |
| Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
| Oxytocin receptor | 0 | 1 | 0 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |